AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
References
This article was originally published at TechCrunch AI. For the full piece, read the original article.
Discussion
Sign in to comment. Your account must be at least 1 day old.